Department

Conference Highlights

Highlights From the 65th ASH Annual Meeting & Exposition

02/09/2024

The American Society of Hematology Annual Meeting & Exposition was held in San Diego, California, December 9-12, 2023. Read our selection of online news coverage of the conference that features the discoveries, emerging therapies, and...

The American Society of...

02/09/2024

Journal of Clinical Pathways

Conference Highlights

Key Highlights From CPC+CBEx 2023

12/14/2023

The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.

The Clinical Pathways Congress +...

12/14/2023

Journal of Clinical Pathways

Corrigendum

Corrigendum: The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia in the United States: A Cost of Care and Budget Impact Model of Venetoclax Plus Obinutuzumab Sequences

12/14/2023

In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.

In the June 2022 issue of the...

12/14/2023

Journal of Clinical Pathways

Clinical Pathways Forum

Beyond Adherence: Clinical Pathways at Roswell Park

12/13/2023

Mishellene McKinney , MHA, RN, OCN;

For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.

For the August 2023 Clinical...

12/13/2023

Journal of Clinical Pathways

Clinical Pathways Forum

Precision Medicine Testing in Oncology: Benefits of and Barriers to Adoption

09/19/2023

Mishellene McKinney , MHA, RN, OCN;

For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.

For the May 2023 Clinical...

09/19/2023

Journal of Clinical Pathways

Clinical Pathways Forum

A Discussion on the Development of a Clinical Decision Support Tool for the Management of Uncontrolled Cancer Symptoms

04/12/2023

Mishellene McKinney , MHA, RN, OCN;

For the January 2023 Clinical Pathways Forum, representatives from Dana-Farber Cancer Institute and Elimu Informatics discussed the development of a clinical decision support tool to help the management of uncontrolled symptoms in patients...

For the January 2023 Clinical...

04/12/2023

Journal of Clinical Pathways

OCPC: In Session

Highlights of the 2022 Clinical Pathways Benchmark Survey

12/05/2022

Winston Wong , PharmD;

Winston Wong, PharmD, Editor-in-Chief, presents the highlights of the 2022 Clinical Pathways Benchmark Survey results, as presented as part of the Oncology Clinical Pathways Congress in Boston in October.

Winston Wong, PharmD,...

12/05/2022

Journal of Clinical Pathways

Conference Highlights

Highlights From the 2022 Oncology Clinical Pathways Congress

11/15/2022

Katie Herman ;

Craig Ostroff ;

A roundup of presentations from the official annual conference of the Journal of Clinical Pathways, the Oncology Clinical Pathways Congress. This congress spotlights the use and continued expansion of clinical pathways and their effect on...

A roundup of presentations from...

11/15/2022

Journal of Clinical Pathways

Research in Review

Research in Review Focus on Cancer

06/16/2022

JCP Editors

J Clin Pathways. 2022;8(5):12. Immune Checkpoint Inhibitors May Have Been Used Inappropriately in Half of Study Patients With Advanced Cancer Who Were Near the End of Life Immune checkpoint inhibitors (ICIs) have revolutionized the...

J Clin Pathways....

06/16/2022

Journal of Clinical Pathways

Research in Review

Research in Review Focus on Ovarian Cancer

05/20/2022

JCP Editors

J Clin Pathways. 2022;8(4):8-11. Progression-Free Survival Associated With Olaparib With or Without Cediranibvs Platinum-Based Chemotherapy in Women With High-Grade Ovarian Cancer Study findings suggest that neither olaparib monotherapy...

J Clin Pathways....

05/20/2022

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Department

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products